| Literature DB >> 7373336 |
R B Godwin-Austen, J A Twomey, G Hanks, J Higgins.
Abstract
The effects of oxpentifylline were assessed in a double-blind trial in 11 patients with Parkinson's disease already under treatment. No significant improvement was noted. Eight patients developed involuntary movements or a worsening of movements if already present. The significance of this unexpected finding is discussed.Entities:
Mesh：
Substances：
Year: 1980 PMID： 7373336 PMCID： PMC490542 DOI： 10.1136/jnnp.43.4.360
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154